Insider Trading & Ownership - Rodino-Klapac Louise

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Rodino-Klapac Louise
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-24
Purchase
2021-11-29
08:00 am
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
3,780$79.33$299,86765,678
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-21
Exercise
2024-06-25
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
6,250$083,891
(Direct)
View
2024-06-24
Tax Withholding
2024-06-25
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
2,182$164.6483,891
(Direct)
View
2024-06-21
Option Award
2024-06-25
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
11,750$083,891
(Direct)
View
2024-03-07
Tax Withholding
2024-03-11
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
512$120.4968,073
(Direct)
View
2024-03-08
Tax Withholding
2024-03-11
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
909$123.1468,073
(Direct)
View
2024-03-04
Tax Withholding
2024-03-06
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
1,728$125.3269,494
(Direct)
View
2024-03-01
Tax Withholding
2024-03-05
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
778$126.1983,722
(Direct)
View
2024-03-01
Option Award
2024-03-05
8:00 pm
2025-03-01
2034-03-01
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
18,500$083,722
(Direct)
View
2023-11-17
Tax Withholding
2023-11-20
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
4,508$82.9865,751
(Direct)
View
2023-03-08
Tax Withholding
2023-03-10
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
912$153.1970,170
(Direct)
View
2023-03-06
Tax Withholding
2023-03-08
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
1,134$157.2198,082
(Direct)
View
2023-03-06
Option Award
2023-03-08
8:00 pm
2024-03-06
2033-03-06
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
31,500$098,082
(Direct)
View
2023-03-01
Tax Withholding
2023-03-03
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
522$147.5767,716
(Direct)
View
2022-11-17
Tax Withholding
2022-11-21
8:02 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
4,211$108.5267,998
(Direct)
View
2022-03-04
Tax Withholding
2022-03-08
8:00 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
1,216$79.2120,111
(Direct)
View
2022-03-07
Option Award
2022-03-08
8:00 pm
2023-03-07
2032-03-07
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
56,000$0120,111
(Direct)
View
2022-03-01
Tax Withholding
2022-03-01
8:03 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Head of R&D, CSO
572$75.0565,327
(Direct)
View
2021-11-16
Option Award
2021-11-17
8:03 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
40,000$061,898
(Direct)
View
2021-02-28
Tax Withholding(A)
2021-03-10
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
565$86.9721,780
(Direct)
View
2021-03-03
Option Award(A)
2021-03-10
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
15,000$021,780
(Direct)
View
2021-03-03
Option Award
2021-03-05
8:05 pm
2022-03-03
2031-03-03
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
75,000$082,169
(Direct)
View
2020-12-14
Option Award
2020-12-14
8:05 pm
N/A
2030-12-14
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
25,000$025,000
(Direct)
View

Ownership
2020-12-14
8:01 pm
N/A
N/A
Sarepta Therapeutics Inc.SRPTRodino-Klapac Louise
Chief Scientific Officer
0$0138,544
(Direct)
View
(A) Indicate amendment filing.